Navigation Links
New Test for Treatment of AIDS

It is an invention that should be hailed among doctors treating AIDS, and their patients//.

About 10 to 20 percent of AIDS victims are resistant to drugs used in treating them. In other words the strain of HIV affecting them has developed some mutation or genetic change that prevents them from being subdued with anti-AIDS drugs.

Such strains multiply rapidly and make the carrier more prone to develop AIDS, and harder to treat.

Currently the tests that are used to detect drug resistant strains of HIV are not only few, and not that very efficient.

According to scientists Feng Gao and others of the Duke University Medical Center, North Carolina, US, who published their findings in Nature Methods, they have devised a device that is so sensitive to viral mutations or drug resistant strains that they pick up a single mutated virus among 10,000 non–mutated ones.

There are about 30 well-established mutations that make HIV strains resistant to the around 20 drug used to treat AIDS.

The present tests require the total resistant viral count or load to reach 20 percent before they can be identified. When this happens the chance of treating the patient effectively goes down drastically. Meanwhile the doctor would have wasted precious time treating the patient with drugs that do not work.

According to Roger Pebody, treatment specialist for the Terrence Higgins Trust, “If this research leads to a simpler and more easily used resistance test, it will improve treatment outcomes for people living with HIV."
AN
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Test for Treatment AIDS

(Date:5/4/2015)... Greifensee, Switzerland (PRWEB) May 04, 2015 ... entitled “ The Importance of Data Integrity in ... Bob McDowall as guest presenter. This webinar will ... EDT (15:00 GMT). , Data integrity is a ... information submitted to regulatory agencies. However, in recent ...
(Date:5/4/2015)... NORTH HOLLYWOOD, Calif. (PRWEB) May 04, 2015 ... awards program recognizes IPC clinical leaders who have made ... to the patients they serve, both in acute and ... Hospitalist of the Year, Post-Acute Provider of the Year, ... the Year and Specialist Provider of the Year. Recipients ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 EY today ... Check as a finalist for the EY Entrepreneur Of ... The awards program recognizes entrepreneurs who demonstrate excellence ... performance and personal commitment to their businesses and communities. ... a panel of independent judges. Award winners will ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Los ... now offering a more comfortable and attractive alternative for ... of choice for those who have lost teeth. Unfortunately, ... feel insecure or slip at the worst possible moment ... or talks. They can also painfully pinch or rub ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Ticket Down is ... the Colonial Life Arena in Columbia, South Carolina. ... continuation of his “Out There” tour which originally kicked off ... tour is North America and the legendary performer recently announced ... the Wells Fargo Arena on June 21st, in Charlottesville, VA ...
Breaking Medicine News(10 mins):Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2
... Washington, DC (August 21, 2008) It costs money ... environment changes or increases in staffing but those costs ... outcomes, according to research in a Special Issue of ... SAGE. , The guest editorial, "The Importance and Challenge ...
... can still take the cholesterol-lowering drug , , THURSDAY, ... said Thursday that they were investigating whether the ... , The U.S. Food and Drug Administration said ... was investigating a report from the so-called Simvastatin ...
... Calif., Aug. 22 Endocare, Inc.,(Nasdaq: ENDO ... an agreement with,its former CFO, John V. Cracchiolo, ... in exchange for Endocare,s waiver,of certain severance and ... 2008, the Company had budgeted over $875,000 for ...
... acne sufferer shares his way to how he cured his acne ... and stopped wasting money on expensive medications and over-the-counter products. ... ... Presents the scientifically proven method to http://www.acnefreein3daysinfo.com/ [cure acne] ...
... INDIANAPOLIS, Aug. 22 Eli Lilly and Co (NYSE:,LLY) ... approved the use of Cymbalta(R) (duloxetine) for the treatment ... for,duloxetine in Europe -- was issued on 28 July ... Agency,s (EMEA) Committee for,Medicinal Products for Human Use (CHMP) ...
... Hospira, Inc.,(NYSE: HSP ), a ... announced new national agreements with Premier Purchasing,Partners. ... member,hospitals with access to special pricing and ... infusion devices, related,sets and disposables, along with ...
Cached Medicine News:Health News:The challenge of paying for quality nursing care 2Health News:FDA Investigates Possible Vytorin-Cancer Link 2Health News:FDA Investigates Possible Vytorin-Cancer Link 3Health News:Endocare and Former CFO Agree to Terminate Indemnification Agreement 2Health News:Chronic Acne Sufferer Finds a New Scientifically Proven Way to Permanently Clear Skin in 3 Days 2Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 2Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 3Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 4Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 5Health News:Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder 6Health News:Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment 2
(Date:5/4/2015)... 2015 Microbrush International, a leading developer, producer ... restorative procedures, today announced the acquisition of DentiSmart ... sectional matrix system used in dental restorative procedures. ... opportunity to add DentiSmart to our growing portfolio ... VP and General Manager of Microbrush. "DentiSmart,s products ...
(Date:5/4/2015)...  The board of directors of Eli Lilly and Company ... second quarter of 2015 of $0.50 per share on outstanding ... 10, 2015, to shareholders of record at the close of ... Company Lilly is a global healthcare leader that unites caring ... world. We were founded more than a century ago by ...
(Date:5/4/2015)... , May 4, 2015 PAREXEL International Corporation ... presenting at the UBS Healthcare Conference on Monday, May 18, ... Vice President and Chief Financial Officer will be making a ... ET. A live webcast of the presentation will ... www.PAREXEL.com in the Upcoming Events portion of the ...
Breaking Medicine Technology:Microbrush International Announces Acquisition of DentiSmart 2PAREXEL International to Present at UBS Healthcare Conference 2
... DEERFIELD, IL, June 04, 2007,/PRNewswire-FirstCall/ - Cardiome ... US, Inc. ("Astellas") today,announced results from their ... 2. The trial evaluated the efficacy and ... (iv)") for the treatment of patients who ...
... -- ZymoGenetics,Inc. today announced that interim findings were ... in B-cell chronic,lymphocytic leukemia (B-CLL) at the American ... study included intravenous,administration of higher doses than had ... atacicept was well-tolerated and biologically,active at all dose ...
Cached Medicine Technology:Cardiome And Astellas Announce Positive Results From ACT 2 Trial 2Cardiome And Astellas Announce Positive Results From ACT 2 Trial 3Cardiome And Astellas Announce Positive Results From ACT 2 Trial 4Cardiome And Astellas Announce Positive Results From ACT 2 Trial 5Cardiome And Astellas Announce Positive Results From ACT 2 Trial 6ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3
... Contoured Sole / Shock Absorption: , The ... and also results in a comfortable and natural ... return feature will absorb a significant portion of ... benefit is reduced pain and increased comfort during ...
... This versatile walker contains all the features ... the latest technology in rehabilitation care at an ... a graduated control of motion. Walker can be ... stops between 0 and 45 degrees of dorsi ...
... Intended to replace total contact casting ... preulcerative conditions of the plantar surface ... include moderate to severe plantar fasciitis ... and would benefit from even distribution ...
... The High Tide walker provides comfortable ... injuries of the lower leg, stress fractures ... stable fractures of the ankle. Extension pads ... larger patients.The shorter Low Tide walker with ...
Medicine Products: